Mometasone Aristo

Medicinal product

(Invented) name

Mometasone Aristo

Active substance (s)

Mometazono furoatas

Strength

50 µg/dozėje

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD09, Mometasone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-03-07

Date of renewal

Documents

2416_Mometasone Aristo 50mcg_nosies_purs_PL_OTC_2025-03-07.docx

2416_Mometasone Aristo 50mcg_nosies_purs_PZ_Rp_2025-03-07.docx

2416_Mometasone Aristo 50mcg_nosies_purs_PZ_OTC_2025-03-07.docx

2416_Mometasone Aristo 50mcg_nosies_purs_PL_Rp_2025-03-07.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kiekvienoje pompos išpurškiamoje dozėje (0,1 ml) yra:	1 dozėje
Mometazono furoatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116919	103023	1103023	buteliukas	60 dozių N1		Nereceptinis	LT/L/25/2416/001	Netiekiama	-	-	No	-	-	Download
116920	103024	1103024	buteliukas	140 dozių N1		Receptinis	LT/L/25/2416/002	Netiekiama	-	-	No	-	-	Download
116921	103025	1103025	buteliukas	140 dozių N3		Receptinis	LT/L/25/2416/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-03-07	Registruotas